5 Dividend Stocks Delivering Rock Solid Fourth-Quarter Income

The article highlights five Nasdaq-listed dividend payers with recurring, regulated or fee-based cash flows: York Water, Willis Towers Watson, Mondelez, Amdocs and Ituran. Key support includes WTW's $1.775B of 2025 operating cash flow versus $358M of dividends and at least $1B of planned buybacks, Mondelez's roughly $3B FY2026 free-cash-flow outlook, and Amdocs' 3.6% yield supported by $749M of operating cash flow versus $224M in dividends. Earnings and operating trends were generally constructive, though risks include York Water's externally financed capex, cocoa-cost pressure at Mondelez, Amdocs' 21% year-to-date share decline and restructuring charge, and Ituran's Israel/Latin America and FX exposure.

Analysis

The relevant distinction is not dividend history but durability after financing needs. YORW's regulated returns do not eliminate its funding gap: persistent capex above internal cash generation makes the equity unusually rate-sensitive for a utility, with higher debt costs or an equity issuance potentially diluting per-share rate-base growth. Its small float also limits institutional tradability; it is not a compelling defensive allocation unless its valuation discounts a materially higher-for-longer rate path.

WTW offers the cleaner quality compounder setup, but the catalyst is execution rather than the sub-1% yield. If management converts the margin program while maintaining buybacks, EPS accretion can outweigh near-term transaction dilution over the next 12-24 months; failure to show sequential organic growth and margin progression would expose the stock to multiple compression versus peers AON and AJG. The less obvious beneficiary of broker consolidation is AJG: acquired-account integration has historically supported cross-sell and retention, making it a more diversified alternative if WTW's integration costs rise.

DOX is the highest-yielded potentially mispriced cash-flow story, contingent on telecom budgets stabilizing rather than reaccelerating. Its managed-services mix and backlog can make earnings less volatile than carrier capex headlines imply, while buybacks create a valuation floor; however, a large customer renewal delay would matter more than a modest EPS beat. ITRN's special dividend should not be capitalized as recurring yield: post-ex-date price adjustment, Israel/LatAm FX and country-risk premia remain the dominant drivers, so the regular subscription trajectory—not the special payment—determines durable upside.

MDLZ is effectively a cocoa-cost and pricing-elasticity trade over the next two quarters. Gross-profit-dollar recovery can support estimates if cocoa normalizes, but a consumer downtrade in Europe would turn apparent margin relief into volume pressure; this favors a relative long against more discretionary packaged-food exposure rather than a broad consumer-staples beta position.

Key Decisions for Investors

• Initiate a 6-12 month long WTW / short AON pair only if WTW sustains sequential margin expansion and organic growth at the next report; target 10-15% relative upside from program execution and buyback accretion. Exit on a guidance cut or evidence that acquisition-related dilution extends beyond the current fiscal year.
• Accumulate DOX over the next 1-3 months on telecom-spending weakness, sized modestly given customer concentration. Underwrite to backlog conversion and managed-services retention, not the dividend; reassess if 12-month backlog declines sequentially or a top-tier carrier defers a material program.
• Use MDLZ as a 6-9 month relative-value long versus discretionary snack/food names with weaker emerging-market exposure, provided cocoa prices continue to ease. Thesis is falsified by two consecutive quarters of negative volume/mix in Europe or failure of gross margin to recover despite lower input costs.
• Avoid chasing ITRN into or immediately after the special-dividend event. Revisit 30-60 days post-ex-date if the price reset creates an entry point and net subscriber additions remain above trend; require stable local-currency growth and no deterioration in cash conversion.
• Do not use YORW as a core income substitute at current information set; monitor financing mix, allowed return outcomes, and credit spreads. A debt-funded capex acceleration or equity issuance would outweigh the defensive-rate-base narrative.